miR-21 contributes to renal fibrosis mediated by MMP-9/TIMP-1 and improves the glomerular lesions induced by TGF-β and hyperglycemia through the repression of proapoptotic signals, which inhibits the loss of podocytes [120]. The gene discussed is MMP9; the disease is Hyperglycemia.